1239363-05-3

Basic information

• Product Name: (S)-N₂-[1-(4-fluorophenyl)ethyl]-N₆-(pyrazin-2-yl)-4-(1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrazol-3-yl)pyridine-2,6-diamine
• Synonyms: (S)-N₂-[1-(4-fluorophenyl)ethyl]-N₆-(pyrazin-2-yl)-4-(1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrazol-3-yl)pyridine-2,6-diamine
• CAS NO: 1239363-05-3
• Molecular Weight: 505.67
• Mol File: 1239363-05-3.mol
• Article Data: 2

Chemical Properties

• CAS DataBase Reference: (S)-N₂-[1-(4-fluorophenyl)ethyl]-N₆-(pyrazin-2-yl)-4-(1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrazol-3-yl)pyridine-2,6-diamine(CAS DataBase Reference)
• NIST Chemistry Reference: (S)-N₂-[1-(4-fluorophenyl)ethyl]-N₆-(pyrazin-2-yl)-4-(1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrazol-3-yl)pyridine-2,6-diamine(1239363-05-3)
• EPA Substance Registry System: (S)-N₂-[1-(4-fluorophenyl)ethyl]-N₆-(pyrazin-2-yl)-4-(1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrazol-3-yl)pyridine-2,6-diamine(1239363-05-3)

Safety Data

• Hazardous Substances Data: 1239363-05-3(Hazardous Substances Data)

Upstream product

• 5049-61-6 2-Aminopyrazine 
• 1239363-03-1 2,6-dichloro-4-(1-{[2-(trimethylsilyl)ethoxy]methyl}-1H-pyrazol-3-yl)pyridine 
• 1239363-02-0 2,6-dichloro-4-(1H-pyrazol-3-yl)pyridine 
• 5398-44-7 2,6-dichloropyridine-4-carboxylic acid 
• 848498-98-6 2,6-dichloro-N-methyl-N-(methyloxy)-4-pyridinecarboxamide 
• 185319-20-4 1-(2,6-dichloropyridin-4-yl)ethan-1-one 

Downstream Products

• 1239359-22-8 (S)-N₂-[1-(4-fluorophenyl)ethyl]-N₆-(pyrazin-2-yl)-4-(1H-pyrazol-3-yl)pyridine-2,6-diamine 

Relevant articles and documents

Therapeutic agent pcnsl (by machine translation)

The present invention provides a malignant lymphoma therapeutic or preventive agent that comprises as the active ingredient a compound represented by general formula [1] as defined by (I) or (II), or a pharmaceutically acceptable salt thereof. [1] (I) X is CH or N; R1 is a halogen; R2 is a halogen, H, a cyano, a group represented by general formula [9], [9] an optionally substituted heteroaryl, or the like; R3 is H or a hydroxyl; R4 is H or an alkyl; and R5 is H or an alkyl. (II) X is -CRA, RA is -CORB, RB is an optionally substituted amino, alkoxy, or saturated cyclic amino group; R1 is a halogen; R2 is H; R3is H or a hydroxy; R4 is H or an alkyl; and R5 is H or an alkyl.